Search research articles
Contact Us
Filters
Showing results (561-570 of 644) with videos related to
Page
of 65
Sort By:
Neurorehabilitation
|
April 3, 2009
Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems
E K Plowman-Prine, M S Okun, C M Sapienza, et al.
Neurology
|
December 29, 2019
Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
Virendra R Mishra, Karthik R Sreenivasan, Zhengshi Yang, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
June 26, 2020
Implementation and Patient Experience of Outpatient Teleneurology
Lindsay Ross, James Bena, Robert Bermel, et al.
Parkinsonism & Related Disorders
|
May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Stuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Journal of Clinical Psychopharmacology
|
June 20, 2024
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 8, 2006
Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease
Lindsy N Williams, Paul Seignourel, Gregory P Crucian, et al.
Journal of Parkinson'S Disease
|
September 19, 2017
App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson's Disease: Reliability and Responsiveness
Dustin A Heldman, Enrique Urrea-Mendoza, Lilia C Lovera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 16, 2016
Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
Thien Thien Lim, Benzi M Kluger, Ramon L Rodriguez, et al.
Bone Marrow Transplantation
|
August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
B S Andersson, J Gajewski, M Donato, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
Inappropriate crying and laughing in Parkinson disease and movement disorders
Mustafa S Siddiqui, Hubert H Fernandez, Cynthia W Garvan, et al.
Page
of 65
Search research articles
Search
Showing results (561-570 of 644) with videos related to
Sort By:
Page
of 65
Neurorehabilitation
|
April 3, 2009
Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems
E K Plowman-Prine, M S Okun, C M Sapienza, et al.
Neurology
|
December 29, 2019
Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
Virendra R Mishra, Karthik R Sreenivasan, Zhengshi Yang, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
June 26, 2020
Implementation and Patient Experience of Outpatient Teleneurology
Lindsay Ross, James Bena, Robert Bermel, et al.
Parkinsonism & Related Disorders
|
May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Stuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Journal of Clinical Psychopharmacology
|
June 20, 2024
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 8, 2006
Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease
Lindsy N Williams, Paul Seignourel, Gregory P Crucian, et al.
Journal of Parkinson'S Disease
|
September 19, 2017
App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson's Disease: Reliability and Responsiveness
Dustin A Heldman, Enrique Urrea-Mendoza, Lilia C Lovera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 16, 2016
Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
Thien Thien Lim, Benzi M Kluger, Ramon L Rodriguez, et al.
Bone Marrow Transplantation
|
August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
B S Andersson, J Gajewski, M Donato, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
Inappropriate crying and laughing in Parkinson disease and movement disorders
Mustafa S Siddiqui, Hubert H Fernandez, Cynthia W Garvan, et al.
Page
of 65